Press Release

View printer-friendly version Back

Lantheus Holdings, Inc. to Present at Upcoming Investor Conferences

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Aug. 24, 2016-- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), today announced that Mary Anne Heino, President and Chief Executive Officer, and Jack Crowley, Chief Financial Officer, will participate in analyst-led fireside chat discussions at the following investor conferences taking place in September 2016.

  • Wells Fargo Securities Healthcare Conference
    September 7, 2016 at 11:05 a.m. ET
    Westin Waterfront Hotel in Boston
  • Baird 2016 Global Healthcare Conference
    September 8, 2016 at 10:15 a.m. ET
    New York Palace Hotel in New York

To access a live webcast of the discussions, please visit the Investors section of the Company’s website at A replay of the webcasts will be available on the Company’s website for 30 days following the live discussions.

About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products. LMI provides a broad portfolio of products, which are primarily used for the diagnosis of cardiovascular diseases. LMI’s key products include the echocardiography contrast agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs. LMI is headquartered in North Billerica, Massachusetts with offices in Puerto Rico and Canada. For more information, visit

Source: Lantheus Holdings, Inc.

Lantheus Holdings, Inc.
Meara Murphy, 978-671-8508